Noreen Parsons
Senior Strategic Advisor Commercial Strategy
Noreen is an experienced industry executive with 25+ years of leading teams in global , regional and local commercial strategy and transformation, pricing and market access, new product planning , portfolio strategy, go -to -market/launch excellence & life cycle management. She has also led an access to medicines consulting business and held board positions for joint ventures in the biosimilar space.
Noreen believes in innovative, dynamic , collaborative and expertise- based approach to optimizing opportunities and problem-solving. She has worked across multiple therapy areas throughout her career and most recently has enjoyed global leadership roles in oncology and immunology.
Her academic qualifications span science and business with a BSc in Pharmacy (Portsmouth) and a MSc in Marketing ( Manchester) and an MBA (Lancaster).
Latest news
Clarivate Launches Derwent Patent Monitor to Enable Fast and Accurate Decision-making with AI
New enterprise solution streamlines IP and R&D patent reviews and accelerates freedom to operate, patentability, and infringement related decisions London, U.K. November 24, 2025. Clarivate Plc (NYSE:CLVT), a leading global provider…
Clarivate RiskMark Wins 2025 LegalTech Breakthrough Award For “LegalTech Predictive AI Solution of the Year”
Annual awards program recognizes companies and products driving innovation in the global legal technology industry AI-powered RiskMark delivers near-instant, data-backed insights London, U.K. November 13, 2025. Clarivate Plc (NYSE:CLVT), a…